Healthcare & Life Sciences
Expedition Therapeutics
United Stateswww.expeditiontx.com
Expedition Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2023
Founded
2
Investors
About Expedition Therapeutics
Expedition Therapeutics is a startup founded in 2023 based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Expedition Therapeutics is a biotech company developing novel therapies for serious inflammatory and respiratory diseases, with a focus on targeting neutrophilic inflammation in chronic obstructive pulmonary disease (COPD) through its lead candidate, EXPD-101, a DPP1 inhibitor.
Explore Expedition Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.